Presentation 1 Annual Report

2015 – 2016

1

Contents

Description Slide number Description Slide number

Chair’s Statement 3 Driving innovation 44

Impacts at a glance 4 Innovation centres 50

Chief Executive’s Statement

5 Supporting staff and creating a

culture of innovation

54

About us

6 Digital health 64

Looking back 2015 - 2016

17 Sharing and learning with

partners

71

Clinical innovation programmes

19 Looking forward 80

North West Coast Patient

Safety Collaborative

27 Financial performance 82

Communications and

engagement

31

Business support and

engagement

33

2

Chair’s statement By Gideon Ben-Tovim OBE

It has been my privilege to chair the Innovation Agency, the Academic Health

Science Network (AHSN) for the North West Coast during a dynamic year in

which we have seen real evidence of our impact.

We are now three years into our five year licence and I am proud to say that we

have built an impressive network of organisations and individuals with the same

aspiration for our region – to overcome the barriers to improving health and

achieving economic growth, through innovation and collaboration.

Much of our work is medium to long term, such as our role in the Connected

Health Cities programme; the EU funded ENSAFE, StopandGo and ALTAS

programmes and the 100,000 Genomes project. Some projects yield quick wins

– such as introducing a local business to an NHS partner in need of particular

expertise or new technology, or helping to bring in big European grants - and

there are some great examples in this report.

We have supported national programmes such as the National Innovation

Accelerator, SBRI programme and worked with our key stakeholders to identify

and respond to the needs of our region resulting in Test Bed and two Healthy

New Town sites.

I would like to thank everyone who has worked with us in the past year in any

capacity; I look forward to continuing to work with you to achieve our shared

objective of using innovative approaches to improve the health and economic

wellbeing of the North West Coast region.

3

Presentation 1

Impacts at a glance 15/16 Delivery of an Atrial Fibrillation (AF) public awareness

raising campaign. Tested 502 and identified 46 irregular

pulses and recommended ongoing support, reducing the

likelihood of stroke - saving £23,000 per person in NHS and

care costs in the first year alone, i.e. a potential £1 million.

Development and launch of a commissioning toolkit for the

treatment of atrial fibrillation, which could potentially save

600 strokes per year in our region per year – a saving of

£13.8M per year.

Over 100 AliveCor devices were deployed. These devices

allow instant detection of atrial fibrillation.

With the Clinical Network delivered an evidence into practice

programme for patients with heart failure. Over 200 patients

have benefited.

Funding and development of the e-strata system: 15,000

e-referrals were made producing:

• a reduction in unproductive nursing / social care time

resource worth over £300,000

• a reduction in reliance on paper, fax, filing and copying

of patient files, by both senders and receivers valued at

around £20,000

One of five AHSNs that provided funding and support for

the NHS National Innovation Accelerator. Three million

patients and 68 NHS organisations are already benefiting

from the impact of NIA innovations. The 17 fellows have

received c £8 million of contracts.

Supported the ‘Refer to Pharmacy’ programme between Oct

2015 and April 2016 1,634 referrals were made to over 150

community pharmacists.

Supported the 100,000 genomes transformation

programme rollout into seven trusts across our region and 390

citizens, who were recruited into the programme. Our

Genomics Ambassador will continue this rollout alongside our

partners in 2016/17.

Through the successful implementation of focused business

support programmes we have:

• Actively engaged with over 500 companies

• Provided intensive support to 85 companies

This had led to jobs safeguarded 53, jobs created 56, new

products or services introduced 76, further investment

leveraged £5,832,685

Developed an Evidence in Innovation Strategic Insight Tool

(EiSIT) for NHS England which supports CCGs to commission

using evidence.

Recruited and developed 50 Innovation Scouts.

Supported/ funded 10 Health Innovation Centres

Increased our social media profile Twitter impressions

increased by 326% to from 54,900 to 178,900 in Jan 2016.

4

Presentation 1

A year of strong collaborations By Chief Executive Dr Liz Mear

We are often asked about our unique selling point and this year it has been our ability to build

strong partnerships to overcome barriers to innovation and to take action.

We have used the principles of co-design, co-production and co-funding to develop and deliver a

number of clinical programmes and technologies which will reduce health inequalities and deliver

improved outcomes for residents. We have invested resources alongside partners into a number

of initiatives which will improve the health and care infrastructure of the region over the next

decade. We have extended our network of Innovation Scouts and now have 50 scouts, who

form our extended innovation network, across the region.

Our role leading the Patient Safety Collaborative enables us to support safety in care right across

the tertiary, secondary, primary and care home systems.

We are being increasingly effective in networking our health, university and local authority

partners and winning funds for these collaborations. We have recognised and grasped

opportunities to roll out precision medicines and digital health as part of our strategy for

preventing illness and improving health across the region over the next decade.

We engage with industry through events, delivering business assist programmes, practical advice

and matching products to receptive NHS trusts. We have a focus on procurement, which

involves developing national and local procurement processes to be enablers of innovation. We

are a champion for the small and medium sized enterprises in our region who can add much

value to the NHS. We also work very closely with our research and innovation hubs and our

Collaboration for Leadership in Health Research Care (CLAHRC) and Comprehensive Research

Network (CRN). This results in commercial research opportunities being available for life

sciences partners in our region and beyond.

Through our system integrator role we have supported our new models of care sites to deliver an

effective and efficient service for our residents, as highlighted in the Five Year Forward View.

We look forward to making an impact to the lives of residents and staff over the coming years.

5

Presentation 1

About us

6

Presentation 1

What our partners say “Making innovation in the NHS actually happen instead of just talking about it, the Innovation Agency are a breath of fresh air.

“Taking the inertia out of the NHS and injecting some real pace into the system, they have rocket-fuelled our projects.

“With backers like this we couldn't fail.”

Mr Iain Hennessy, consultant surgeon

Clinical Director of Innovation

Alder Hey Children’s Hospital

7

Presentation 1

Partners’ testimonies “The Innovation Agency enabled us to test our product-market fit, to be able to tailor our approach and target the key clinical touch points where we would add the most value. I have found the encouragement, belief and support for us as a company and me personally to be invaluable as we scale this innovation in the NHS.”

Francis White, AliveCor Ltd

NHS Innovation Fellow

“In the last year we have tested more than 300 genomes

and were rated the third best in the country; we couldn’t

have done that without the support of the Innovation

Agency.”

Lynn Greenhalgh, Clinical Director of Genetics,

NWC Genomic Medicine Centre

8

Presentation 1

Partners’ testimonies

“We received a grant from the Innovation Agency to support an innovation project to improve self-management for patients with COPD.

“We have worked hard on a collaborative EU grant aiming to design and implement a Public Procurement of Innovations at scale in Europe which, if successful, will bring considerable sums of money not only into our research and innovation service line but into the clinical services directly - making a massive difference to our financial position.

“We have formed a collaboration with 3DLifePrints which resulted from a tour of the innovation space at Alder Hey during one of the Innovation Scout days, led by the Innovation Agency.

“The Scout movement has created considerable networking opportunities that come from being brought together to focus on this part of our jobs.”

Dr Mark Jackson, Innovation Scout

Director of Research and Informatics, Liverpool Heart and

Chest Hospital NHS FT

9

Presentation 1

Partners’ testimonies

“Getting onto the NHS supplies framework is a

massive achievement for us and has helped us to

attract further investment to step up production. It is

only as a result of the intervention of the Innovation

Agency’s commercial team that we were able to break

through barriers to joining NHS frameworks, such as a

requirement for a £1 million turnover.

“It was the breakthrough we were waiting for; there is

strict governance in the health service which means

that only a limited number of approved companies are

allowed to provide supplies.”

Dr Jonathan Day

Managing Director, Leanvation

10

Presentation 1

Partners’ testimonies

“The Centre for Integrated Healthcare Science based at Bache Hall in Chester, is a joint venture between the Countess of Chester Hospital and the University of Chester to develop a shared centre for research, innovation and medical education. It has been supported by both the Innovation Agency and the local Clinical Research Network. Other partners include Cheshire and Wirral Partnership Trust, and West Cheshire CCG. The Centre is intended to promote and test innovation and new ways of working, while enhancing the local delivery of health and social care research, and further medical education.”

Steve Bridge

Associate Director & Innovation Scout

The Centre for Integrated Healthcare

Science, Chester

11

Presentation 1

Partners’ testimonies

“We're really pleased to be part of the Innovation Agency.

“It has helped us enormously in getting a much better sense of how we as a university can best contribute to improvements in health and healthcare through innovation. It has also provided a really effective forum for beginning to work through how we develop the North West Coast as an academic health system.”

Professor Neil Johnson

Dean

Faculty of Health & Medicine

Lancaster University

12

Presentation 1

Partners’ testimonies

“The active support and involvement of the senior executives within the Innovation Agency has enhanced the work of NHS NW Procurement Development to deliver training and awareness sessions that open up a range of possibilities for the NHS Procurement community.

“The NW region has benefitted by embracing the benefits of innovation and closer working relationships with suppliers, augmented through the AHSN commitment in supporting the NW Excellence in Supply Awards, a unique event in the English health service.

“Innovation and procurement are inextricably linked and NHS NWPD are delighted to be able to continue to support the Agency in its quest for the wider adoption of new technologies.”

Mick Guymer

Director

North West Procurement Development

13

Presentation 1

Vision and Goals 2016/17 The Innovation Agency’s vision is focused on

adopting innovation where it can have most impact.

Our goals are to:

• Accelerate the delivery of safer, better care

• Develop a network of health innovation centres

• Support economic growth through SMEs and

industry

• Drive digital innovation that empowers citizens

and the workforce

The Innovation Agency covers South Cumbria,

Cheshire, Merseyside and Lancashire. This area

has a population size of 4.1 million and contains

vibrant cities, coastline and countryside.

Our core purpose is to spread innovation,

improve health, generate economic growth

The Innovation Agency is governed by a Board of

40 representatives from NHS, academia and

industry. The Board meets at least five times a year

and members are expected to attend at least three

out of five meetings to ensure that the AHSN

achieves its goals and objectives and complies with

all relevant performance metrics.

14

Presentation 1

Innovation Agency values

Working together for

patients

Respect and dignity

Commitment to quality of

care Compassion

Improving lives

Everyone counts

The Innovation Agency has adopted the values in the NHS Constitution

In addition, we have developed additional values which reflect the way we work

Do things differently

•Entrepreneurial innovation

•Creative implementation

•Commitment to positive, sustainable change

Clear Space for

•Reflection, creativity and planning.

•Making work fun and productive

Courageous & achievement

focussed

•Risk taking and challenging status quo

•Sharing responsibility and commitment for innovation adoption

•Going the extra mile

Co-creation, co-design, co-resourcing

•Engaging and forming collaboration with and between partners

•Networking

•Sharing ideas

•Sharing resource to fund projects

Team Work

•Supporting each other

•Sharing skills and experience

•Developing a team working environment

•Being flexible

15

Presentation 1

Innovation Agency Board – we are governed by a board of 40 representatives from local organisations • Provider trusts

• Commissioners – CCGs and NHS England

• Strategic Clinical Network

• Local Enterprise Partnerships (LEPs)

• Public Health England

• Health Education England and Local Workforce Education Groups (LWEGs)

• Universities

• NIHR Clinical Research Network: NWC

• NIHR Collaboration for Leadership in Applied Health Research and Care North West Coast

• Association of British Pharmaceutical Industry (ABPI)

• Association of British Healthcare Industries (ABHI)

• Healthwatch

• Research and innovation hubs

16

Presentation 1

Looking back 2015 - 2016

17

Presentation 1

Copyright ©

2015 NWC

AHSN

1

Work with commissioners and

public health

Rapid Spread of Research and

Innov ation into Practice

Build a culture of partnership and

collaboration

Core Platforms

Cross Cutting Workstreams

Improv ing Economic

Growth

Str

oke

Menta

l hea

lth

Mu

sc

ulo

sk

ele

tal i

nn

ov

atio

nR

edu

ce a

lcoho

l re

late

d A

&E

att

end

anc

es

Medic

ine o

pti

mis

ati

on a

cro

ss

the

sy

ste

m

Paedia

tric

/Adult c

are

tra

nsi

tion

Hy

dra

tion

Sepsis

Tec

hno

logy

for

saf

ety

Support

to a

void

fra

il eld

erly

adm

issio

ns

Good p

ractice C

are

Hom

es p

rogra

mm

e

Health a

nd w

ellb

ein

g o

f sta

ff

Leaders

hip

Measure

ment

Sy stem integration

Use of technology

Procurement

Innov ation culture

Ef f ective partnerships

Digital health / data integration

Resident inv olvement

Prev ention & early detection of disease

Business support

Reducing health inequalities

Future workf orce

Using Greenspace in health

Precision Medicine

Safety Clinical

Goals and priorities 2015/16 – we achieved all our

priorities

18

Presentation 1

Clinical innovation programmes

19

Presentation 1

Stroke/Atrial Fibrillation (AF) Reducing AF related strokes continues to be a

priority for the Innovation Agency. Our work in

the last year included:

• An AF public awareness raising

campaign delivered across Lancashire. This

was a collaborative campaign working with

charities, NHS, media and Strategic Clinical

Networks. We tested 502 pulses and

detected 34 abnormal pulses. We used

technology including MyDiagnostick, to

support our work and engage with the public.

• Genotype guided dosing for warfarin

(Gen-warf) a project jointly funded by the

NIHR CLAHRC NWC, LGC and the

Innovation Agency, started operations at the

Royal Liverpool University Hospital, with the

Countess of Chester and Warrington

Hospitals starting soon. Comparator sites

are Lancashire Teaching Hospital, St

Helens and Knowsley Hospitals and Aintree

University Hospital. An Evaluation is

ongoing.

• Over 100 AliveCor devices were deployed

with GPs and community nurses in

Warrington, South Sefton, Liverpool, Halton,

East Lancs and Greater Preston. An

Evaluation is underway.

• Supported the development of the AF CCG

Commissioning Tool-kit, with Greater

Manchester, Cumbria and Lancashire

Strategic Clinical Networks

• Supported the AF Clinical Pathway, with the

Strategic Clinical Network, which has also

been adopted in other regions of the country

• Supported the use of MyDiagnostick with a

range of health professionals

• Facilitated the introduction of Cardiocity

technology in three practices in our region

• Supported UCLAN with the commissioning of

the Stroke Specific Education Framework

http://www.stroke-education.org.uk/website

20

Presentation 1

Stroke/Atrial Fibrillation (AF) • MyDiagnostick

Evaluation is being carried out by UCLAN in East Lancs

and devices have been deployed with a range of

professionals in Halton, including staff in adult social

care.

• We introduced monitoring of warfarin at the point of care

– in care homes. Helicon Health and Roche are

supporting us in this work

• Online training for clinicians

A package from Helicon Health was piloted with several

clinicians to look at whether the training provided

suitable support for ongoing training needs.

• Hospital AF audit

We have supported three of our local hospitals in

carrying out an audit of over 500 patients identified with

AF during a hospital visit. This is already leading to

improvements in communication with primary care.

21

Presentation 1

100,000 Genome Project

Across the NW Coast we will recruit 5000 patients with cancer

and rare diseases, involving all our Local Delivery Partners (nine

NHS health and social care organisations) to improve the health

and economic growth of our population. Recruitment will include

a range of cancers and rare diseases across all medical

specialties supported by genomics-trained recruitment nurses

and their multidisciplinary teams.

Rare diseases

• Recruitment is ongoing, having started in April 2015, and so

far a total of approximately 300 patients have been recruited

into the project. The results for these patients are expected

be returned by June 2016, when they will need to be

validated and reported. The Rare Diseases Recruitment

Teams successfully recruited within 80 per cent of the

contracted patient numbers against a national average of 67

per cent.

Cancer

• October 2015 saw the first cancer patient recruited into the

Initial Implementation Phase of the project from the Royal

Liverpool and Broadgreen University Hospitals NHS Trust.

Since then a further nine patients have been successfully

recruited. We expect to receive the patients’ results back in

about 12 months time

• Two further organisations are awaiting imminent ‘go live’

status to recruit lung cancer and ovarian cancer patients;

Liverpool Heart and Chest Hospital NHS Foundation Trust

and the Liverpool Women’s NHS Foundation Trust

• In 16/17 patients will be recruited from the

Countess of Chester NHS Hospital Trust and

Lancashire Teaching Hospitals NHS Trust

• Work is being undertaken to recruit patients

with a soft tissue sarcoma diagnosis,

predominantly from the Royal Liverpool and

Broadgreen University Hospitals NHS Trust

• Alongside the work being done to embed the

transformation of diagnostic services into

existing patient pathways, the North West

Coast Genomics Medicine Centre has worked

with a digital system integrator to develop and

implement a bespoke data collection system.

This system is a platform enabling all

organisations throughout the North West Coast

GMC to register and collect data on each

patient that is recruited into the project and to

send this data to the National Biorepository

• This specialist dataset will become a valuable

resource for future care planning

• In 16/17 we have funded a Genomic

Ambassador post so that all organisations in

our region can participate in this programme

22

Presentation 1

100,000 Genome Project

23

Presentation 1

Other clinical programme achievements • Alcohol

Harms caused by alcohol remain a huge problem for our

region; we have some of the highest rates of related morbidity

and mortality in the UK. We developed a support package to

amplify the Dry January campaign delivered by Alcohol

Concern and a local company Red Ninja. We are looking at

whether such campaigns contribute to reducing alcohol harms

and whether certain months such as January offer teachable

moments. The evaluation will report in June 2016

• Musculoskeletal Innovation

West Lancashire CCG and Southport and Ormskirk Hospital

have been supported in the funding and development of a

Musculoskeletal Online Support Service (MOSS) for people

with musculoskeletal problems. We are working with a local

company Citrus Suite and Physitrak and the service will go

live in July 2016.

• Heart failure

South Sefton CCG and MSD delivered an evidence into

practice programme for patients with heart failure in 6

practices. Over 200 patients will have benefited from this

package.

• Enhancing capacity in using evidence in innovation

We developed an Evidence in Innovation Strategic Insight

Tool (EiSIT) for NHS England which supports CCGs to

commission using evidence in a consistent way. This will be

launched nationally in 2016. Our team is developing case

studies in CCGs in our region to examine how it works in

practice. We have supported the development of an

infographic to support this work.

24

Presentation 1

Medicines optimisation A ‘Refer to Pharmacy’ project at East Lancashire

Hospitals allows hospital pharmacists and pharmacy

technicians to refer patients directly to their

community pharmacist for free NHS services such as

the ‘New Medicine Service’ or a ‘Discharge Medication

Review’.

Patients receive a copy of their referral by text or e-

mail, shortly after they leave hospital. Their chosen

community pharmacist then contacts them to arrange a

convenient time to meet and discuss changes to their

medication.

More than 150 community pharmacists are registered

and more than 1000 referrals were made in the first

three months of ‘Refer to Pharmacy’, making an

immediate impact on the lives of our residents.

The Innovation Agency has supported this programme,

created marketing opportunities and funded

benchmarking of the programme against similar

programmes in other regions.

25

Presentation 1

Collaborations with other AHSNs

Stroke prevention

Our public awareness campaigns reached over one million people. We identified 46 irregular pulses in people who had not been previously diagnosed with atrial fibrillation (AF). Potentially this may prevent 46 strokes if patients are treated. Other AHSNs have also developed campaigns following this success.

We have teamed up with Greater Manchester AHSN who developed an AF dashboard. This is now available to NWC CCGs. It draws together all the AF data from a range of different sources and supports our ongoing improvements in this area.

The next step in our plan is to consolidate our work in technologies for identifying stroke and develop an AF Collaborative which provides bespoke support for challenged areas, which includes, technology, education and improvement techniques. We will be using the “Don’t wait to anti-coagulate”, model of improvement from the West of England AHSN.

Musculoskeletal care - STarTBack

The STarTBack programme was developed and evaluated by

colleagues at Keele University, supported by West Midlands

AHSN, to improve the management of back pain in primary care.

Its efficacy has been demonstrated in several studies published

in journals such as the Lancet as it:

• Significantly reduces time off work by 50%

• Saves money (approx. £34 per patient)

• Significantly reduces disability

We have been supporting the rollout of StarTBack and those

using the model, in our region now includes all Liverpool GP

practices and practices in St Helens, East Lancashire and Wirral

reaching approximately 80,000 patients with lower back pain per

year. We will continue to support the CCGs and practices in

rolling this out and a local evaluation is planned for summer 2016

26

Presentation 1

North West Coast Patient Safety Collaborative

27

Presentation 1

Patient Safety Collaborative achievements

The Patient Safety Collaboratives (PSC) were set up within each of the 15 AHSNs to ensure

patient safety remains a number one priority by reducing avoidable harm, saving lives and

creating a comprehensive, effective and sustainable improvement system.

Some of the key achievements against our priorities include:

• Engaging members and service users in the development of a NWC Safer and Better Care

Strategy through ‘listening’ events

• Shared funding for an e-discharge project, enabling electronic discharges for patients leaving

hospital settings for local authority, hospice and care home settings. This project supports safer,

speedier discharges and is about to be rolled out to 5,000 care home beds, so far there has

been more than 15,000 e-referrals in Cumbria alone.

• Completion of phase II of a project to develop a software tool which enables team of clinicians

to review anonymised serious events and to identify learning points. Now being used in two

large foundation trusts in our region, with growing interest from other trusts.

• Development of e-learning packages :

- Hydration, including acute kidney injury (care worker focused), and sepsis

28

Presentation 1

Patient Safety Collaborative achievements

• Co-production of a measurement strategy with Haelo and further commissioned phase II work for

maintaining and developing a safety measurement dashboard in relation to the ‘Sign Up to

Safety’ improvement plans

• Creating virtual learning networks to build capability around the care of frail elderly people and

staff health and well being

• Collaborating with and supporting the roll out of the NHS England ‘Sign up to Safety’ campaign.

Twenty five organisations are now members, including three CCGs.

• Jointly facilitating the ongoing development of 10 Q Improvement Fellows appointed as part of

the Q Initiative with Greater Manchester AHSN and AQuA

29

Presentation 1

Patient Safety Collaboratives National Sepsis Cluster The Innovation Agency Patient Safety Collaborative leads the national sepsis cluster group which involves a number of AHSNs.

We have secured membership on the NHSE National Cross System Sepsis Board that has developed the national sepsis action plan.

The cluster has shared a number of case studies nationally with the Board and has agreed a set of actions within the plan.

This involves:

(a)supporting the implementation of professional training across care settings;

(b)supporting local organisations to identify best practice and innovation for better care pathways

(c)supporting local organisations to identify and spread best practice, improving communication between settings and transfers of care.

30

Presentation 1

Communications and engagement

Our organisation was rebranded to support our vision and

strategy, reinforcing our focus on innovation spread and adoption.

This followed a consultation exercise carried out with key partners

and stakeholders.

From March our name was changed to the Innovation Agency,

while retaining as a strapline the description: Academic Health

Science Network for the North West Coast.

To strengthen the communications function, a Director of

Communications and Engagement was appointed in September

2015 and a specialist was recruited to the additional role of Events

Manager.

A total of 51 events were organised in the year, some in

partnership with other organisations.

Media coverage: A media monitoring service was started in

January 2016 and in the following three months, there was a total

of 89 items of media coverage including national, regional, trade,

digital and broadcast.

A total of 44 press releases were issued in the year 2015-16.

In February 2016, we led on the production of a Super North

supplement in The Times focussed on the work of the four AHSNs

of the North.

31

Presentation 1

Social media and events Social media plays an important part in

growing our networks and in showcasing

good practice and innovation.

Our Twitter following has grown to over

2,600 and we now have 167 videos on our

YouTube channel.

Staff and partners regularly blog about our

work and Twitter and LinkedIn are used to

drive traffic to the blogs, on our website.

On LinkedIn, as well as a company page

with 227 followers, we have also created a

group page for Vanguards of the North, with

36 followers. This was created after an

event that we organised, attended by ten of

the Northern Vanguards.

A wide range of event formats is used by

the Innovation Agency and in the past year

these have included ‘unconferences’ and

hackathons.

Two senior members of staff have been trained by MIT and are now

hackathon experts, able to support partners in delivering events such

as the Alder Hey Children’s Hospital ‘Hacking children’s health’; and

the Central Cheshire System Resilience Group hack.

In partnership with the NIHR CLAHRC NWC and the CRN NWC, we

organised a North West Coast Research and Innovation Awards

event in November 2015, attracting more than 120 nominations and

celebrating 12 winners at an event held at Chester Racecourse

attended by key stakeholders and staff from all sectors.

32

Presentation 1

Business support and engagement

33

Presentation 1

Summary of business support activity

Through the successful implementation of

focused business support programmes we

have:

• Actively engaged with over 500 companies

• Provided intensive support to 81 companies

This had led to:

• Jobs safeguarded - 53

• Jobs created - 56

• New products or services introduced - 76

• Further investment leveraged - £5,832,685

The Commercial team has worked with the

regional LEPs to deliver business support

services across the region.

For the Lancashire region we worked alongside

the Boost programme for business support.

In Cheshire and Warrington we facilitated a

series of networking events and completed a

research study with SMEs to better understand the

barriers to supplying the health sector.

In the Liverpool City Region we ran the New

Markets programme for NHS Engagement.

Businesses were able to participate in various

workshops including:

• Health economics

• Business case development for the NHS

• Funding options for SMEs

34

Award sponsorship Awards are an excellent way to identify and showcase best practice and innovation. In the past year, we sponsored the following industry awards:

• Excellence in Supply Awards (through North West Procurement Development)

• Red Rose Awards, celebrating Lancashire business, commerce and industry

• Bionow Awards, showcasing the best of the Northern life sciences sector

• North West Medilink Healthcare Business Awards celebrating innovation, growth and commercial success in the Healthcare Technologies and Life Sciences sector

• NW Informatics Awards, hosted by the Skills Development Network

We also organised the first North West Coast Research and Innovation Awards, in partnership with the NIHR CLAHRC NWC and the CRN NWC.

35

Presentation 1

Procurement best practice

Excellence in Supply Awards

More than 300 guests attended last year’s NHS in the North

West Excellence in Supply Awards, sponsored by the

Innovation Agency. The event recognises the contribution of

suppliers and the NHS procurement profession to supporting

patient care and reducing costs.

NHS Blood Bikes, Lancashire and Lakes won the ‘Supplier of

the Year’ title for their voluntary service which transports blood

and other lifesaving products around the region on

motorbikes. Their work frees up resources for NHS trusts to

re-invest in front line care. The award highlights the key role

played by voluntary and third sector organisations in the NHS.

Innovation Agency Chief Executive, Dr Liz Mear, is Chair of

NHS North West Procurement Development and presented at

the event.

The achievements highlighted by the awards show how, by

working together, the NHS, third sector and industry can

simultaneously achieve both high quality patient care and

value for money through procurement.

36

Presentation 1

Procurement workshops

We ran a series of workshops about innovation procurement,

attended by Innovation Scouts and their associated Heads of

Procurement. The workshops cover theory, principles and

practice in line with recent changes to EU Guidelines and

have enabled our Innovation Scouts to better appreciate the

complex nature of procurement in the NHS.

A series of Procurement Surgeries were also held for SMEs in

conjunction with North West Procurement Development.

These enabled our local SMEs to get valuable one-to-one

sessions with procurement experts to better understand the

issues around supplying to the NHS.

We have an ongoing collaboration with North West

Procurement Development and the Royal College of Nursing

to drive the procurement of innovation in the North west with a

project called “wouldn’t it be great if….”.

We are a partner in StopandGo, a Public Procurement of

Innovations pilot project.

37

Presentation 1

Examples of business support successes Local Enterprise Partnerships

The business assist programmes established with Liverpool City

Region, Lancashire, and Cheshire & Warrington Local Enterprise

Partnerships have enabled the commercial team to engage with

numerous SMEs in 2015/16. Examples follow below.

Leanvation

With help from the Innovation Agency, Leanvation has overcome the

rigorous processes involved in securing three framework award

contracts with SBS, HTE and NHS Supply Chain.

This means that Leanvation’s latex-free surgical gloves are now

available to NHS trusts throughout the country.

The company received £500,000 venture capital investment; three

jobs have been safeguarded and an additional six posts have been

created in this St Helens-based start-up.

38

Presentation 1

Examples of business support successes - AIMES AIMES, a multi award winning commercial data

centre service provider based in the North

West of England, is one of the companies we

have worked with.

Dennis Kehoe, Chief Executive of AIMES, said:

“The work the Innovation Agency has been

doing within the North West has been

integral to a number of our strategic

initiatives. Our N3 Aggregation in

conjunction with Liverpool CCG was funded

by the Innovation Agency. This has allowed

us to deliver a variety of secure, cloud-

based digital health services much more

quickly, bringing benefits to the population

across a number of clinical pathways and

generating economic growth, not just for

AIMES but for digital service developers.

The Innovation Agency’s Ecosystem events

have led to collaboration across academia,

industry and the NHS.

“We’ve exploited these links by getting our

partners within the NWC such as Lancashire

Care involved in Horizon 2020 proposals.

“Most significantly, our engagement with the

Innovation Agency has given rise to AIMES

being tasked with delivering the Data Ark for

the Connected Health Cities Project. These

projects put AIMES at the centre of health

data hosting, and enables our business to

play an active role in the emergence of digital

health technologies within the NHS.

“With the pro-activeness of the Innovation

Agency, their work in promoting inward

investment from digital health service

providers across the country, we’ve been able

to play a role in facilitating the success of the

Innovation Agency.”

39

Presentation 1

Delivering efficiency and supporting enterprise

Innovations with Impact

Our Innovations with Impact funding competition was advertised

widely across the NWC region and following a well-attended

information day, almost 50 applications were received.

Applications were assessed against questions posed in the

application form by a range of reviewers including the regional

NHS England and Strategic Clinical Network teams, academics,

Innovation Scouts and North West Procurement Development

Agency.

The robust scoring process was designed by GE Healthcare.

Applications were scored against a range of criteria, including

whether the same technology was included in another

application already recommended for funding and which of

these applications provided the most benefit, the fit with current

work streams and priorities and potential level of impact

(number and range of organisations involved and / or number of

service users benefiting).

Following this review, the executive team recommended 18

applications for funding. The total funding for projects was

£426,000. All suppliers are SMEs and seven are based in the

NWC region.

One beneficiary is Alder Hey Children’s Hospital

who will receive over £49,000 to fund two

developments. One revolutionary project, and a

first for Liverpool, is the SMARTinhaler, designed

to remind parents and children to take their

asthma medication. It will also incorporate a

touch screen questionnaire to record the

recurring symptoms of an asthma attack.

By recording the symptoms of the attack, it will

give doctors and patients a clear understanding

on what causes the incident and how it can be

avoided in the future.

40

Presentation 1

SBRI update The Small Business Research Initiative (SBRI) for

Healthcare brings together business, health,

technology and government partners to deliver a

series of competitions for businesses to address major

unmet health needs.

Unlike many Research and Development projects

which offer grant or match funding, SBRI contracts are

100 per cent funded and the inventor retains the

intellectual property.

As part of Innovation Health and Wealth, the SBRI

Healthcare programme sets industry the challenge in a

series of health related competitions which result in

fully funded development contracts between the

awarded company and the NHS.

SBRI Healthcare competition themes are chosen in

partnership with the Academic Health Science

Networks (AHSNs) across England.

Karen Livingstone, Director of SBRI Healthcare, said:

‘We are particularly pleased to have been able to

support so many innovative companies given the

financial pressures on the NHS. In 2015 the

programme awarded 28 contracts across the various

phases of the competition,

The North West Coast Region has been particularly

successful over the last year and we will continue to

support all these companies to commercialise their

new technologies.

Eight companies in our region have secured SBRI

funding, to a total of £5.6m. Among the Phase 2

winners are:

Digital Creativity in Design Ltd, Liverpool

Cardiocity Ltd, Lancaster

Biosensors Ltd, Liverpool

Cadscan Ltd, Chester

41

Presentation 1

SBRI example - Cadscan

Cadscan was awarded almost £1m from SBRI Healthcare, a

funding competition that we run, to develop an innovative way of

helping people with diabetes.

Cadscan, in Chester, will be given £961,859 to develop a low-cost,

on-demand system to manufacture effective insoles to reduce the

risk of people with diabetes developing foot ulcers. The system

consists of a 3D foot scanner, 3D insole printer and software that

can automatically design and manufacture a bespoke insole.

On average, 300 new foot ulcers are diagnosed every day and

120 people undergo an amputation each week – 80 per cent of

which are preceded by a foot ulcer. Once developed, the insole

could substantially reduce the £1 billion annual bill for amputation

and £5,500 cost of treating each foot ulcer.

Dr Alastair Buchanan, Managing Director of Cadscan Limited,

said: “With rising rates of diabetes it is important to develop ways

to prevent people developing diabetic foot ulcers rather than

treating them after they have occurred. The money we have been

awarded will be used to develop a product that in the future could

save the NHS millions of pounds each year - and allow patients to

stay healthier and continue to lead more independent lives. ”

The company was founded in 2011 with the aim of lowering the

cost of high-quality 3D scanning.

42

The type of bid writing support provided varied significantly

between each funding bid, and ranged from external assurance

reviews of draft proposals to content development of significant

sections of the bid documentation. We also helped bid teams with

‘mock interviews’ where we gave constructive feedback on

interview presentations and managing interview sessions.

Some examples of the types of support we have provided include:

• Supporting three NHS Innovation Test Bed submissions, initially

with content development and bid review services, and then for

shortlisted projects we helped with interview preparation

• Providing bid development support and QA review for the North

West Coast Connected Health Cities (CHC) proposal. We

provided support with project mobilisation and development of

governance arrangements

• We developed bid content and undertook a QA review of a

Horizon 2020 PCP proposal for digital health enhancement of

COPD services

• We helped with bid qualification on a lBig Lottery Fund proposal

• We helped Alder Hey Hospital identify additional funding

sources to help with the development of the Innovation Hub

facility, and reviewed a Health Foundation proposal from the

Trust

• Delivered training on ‘Top tips for developing a winning

proposal’ for potential SBRI Healthcare submission leaders

• Developed an evaluation process and criteria for the AHSN

‘Innovation with Impact’ funding scheme

• Developed a Strategic Narrative for Digital Health across

Lancashire and South Cumbria (to support coordinated bids for

investment).

We supported a wide range of tender responses, helped with

interview preparation and provided advice and support to numerous

projects throughout the year. Feedback from bid teams has been

extremely positive, both in terms of the content developed and the

constructive challenge that an independent review of documentation

and other materials can provide. A number of these schemes have

been successful in obtaining funding as a result of the support

provided, most notably the Connected Health Cities project which

received £4m investment over three years following its submission in

year.

Bid writing support for key strategic funding initiatives – 2015/16

We asked GE Healthcare Finnamore to help organisations within the North

West Coast AHSN area, which covers most of Cheshire, Merseyside, most

of Lancashire and Cumbria, to:

• Write high quality, high impact proposals for funding from external

sources

• Deliver excellent pitch presentations or clarification interviews when

requested by funding bodies

• Identify funding sources to take forward their local innovation agenda.

The challenge…

The outcome…

Our approach…

43

Driving innovation

44

The aim of the National Innovation Accelerator (NIA) is to deliver on the commitment

detailed within the Five Year Forward View to create the conditions and cultural change

necessary for proven innovations to be adopted faster and more systematically through the

NHS, and to deliver examples into practice for demonstrable patient and population benefit.

We have contributed funding of £100k into the NIA alongside four other AHSNs and an NHS

England contribution.

Circa £9 million for the companies involved has been leveraged for this contribution:

• 66 more NHS organisations are now using NIA innovations since the start of the

programme (14% of all NHS organisations)

• Six awards won

• In addition to supporting the development and ongoing direction of the programme at a

national level, within our region we have supported three NIA fellows:

• Dr Penny Newman, health coaching

• Dr Lloyd Humphries, Patient Knows Best

• Francis White, AliveCor

We have plans to work with a further three fellows in 2016/17 and will continue to support

the programme alongside seven other AHSNs.

National Innovation Accelerator

Dr Lloyd Humphries

45

Presentation 1

Supporting new models of care and the Five Year Forward View

Vanguards

The Innovation Agency is committed to supporting new

models of care. We have six Vanguard sites in our area and

we have provided support by:

• Hosting a number of events where the Vanguards are

brought together to share experiences and ideas

• Proving logic model and Baines model evaluation

support, funding and supporting rollout out of system

modelling tools, advising on workforce redesign,

coaching senior leadership teams and individual leaders

to take their role in system leadership

• Supporting the development of an Invitation to Tender

for evaluation with ongoing support provided for the

commissioning of the evaluation from a suitable provider

• Providing opportunities to develop capacity and

capability in using evidence in the commissioning of

innovative approaches. We are working with a number

of Vanguard areas to develop case studies and look at

supporting teams and Boards to assess and manage

evidence in the commissioning process.

.

46

Presentation 1

Healthy New Towns

The background:

• Britain loses more than 130 million working days to ill health each year

• 19 per cent of children aged 10 to 11 are obese

• Only 21 per cent of children play outdoors compared to 71 per cent of their parents when they were children

• One quarter of adults walk for less than nine minutes per day and physical inactivity is a direct factor in one in six deaths.

The Healthy New Towns programme aims to inform thinking and planning of every day environments to improve health for generations to come.

We supported two bids for sites in the North West Coast and introduced new support partners to each site; and we are supporting the delivery of both projects:

Halton Lea in Runcorn covering 800 residential units, and

Whyndyke Farm in Fylde, Lancashire covering 1,400 residential units. We have started to work with these sites to ensure that digital health technologies can be supportive in improving the health of residents and we will pinpoint specific programmes of work with these sites in 2016/17.

There are 10 sites across the country covering more than 76,000 new homes with potential capacity for approximately 170,000. This is an opportunity for the NHS to shape the way these new sites develop and to test creative solutions for the health and care challenges of the 21st century, including obesity, dementia and community cohesion.

47

Presentation 1

Test Bed success The Innovation Agency was delighted to support the development of a successful Test Bed bid as part of the Lancashire and Cumbria Innovation Alliance (LCIA).

The Test Bed will be delivered through two neighbouring Vanguard sites (Fylde Coast Local Health Economy and Morecambe Bay Health Community) supported by the Innovation Agency and Lancaster Health Hub, an established NHS/University partnership comprising 10 local organisations.

Over two years the partners will implement and evaluate a combination of innovative technologies and practices aimed at supporting the frail elderly, people with dementia and other long term conditions to remain well in the community, avoiding unnecessary hospital admissions.

The Innovation Agency supported the development of the bid and establishment of industry collaborations and has a seat on the Governance Group.

In addition the Innovation Agency is funding a communications manager to focus on promoting the LCIA and engage clinicians and service users engagement,

The Innovation Agency is also responsible for national co-ordination and international aspects of the LCIA.

Out of 14 shortlisted Test Bed sites, three of these applications were from the North West Coast region. The Innovation Agency supported all three shortlisted bids and the two other shortlisted sites - one in Liverpool and one in Cheshire – have each received £50k funding to develop the priority areas of their suggested programme.

48

Presentation 1

International learning and partnerships

• We continued our series of quarterly

European Connected Health Care Alliance

Ecosystem (ECHA) events. These events

network industry, health, social care and

universities to develop e-health and m-

health solutions for citizens

• Led successful study tours to Austria,

Denmark and Slovenia resulting in

adoption of systems and practices in our

region

• Guest speaker at two launch events - of the

China Connected Health Alliance

Ecosystem; and the Poland Connected

Health Alliance Ecosystem, showcasing the

impact of the Innovation Agency in the

NWC

49

Innovation Centres

50

Presentation 1

Infrastructure development

There has been limited infrastructure in the North West

Coast region to support early stage companies in the

health and life science sectors, and existing facilities

were not linked to health service provision.

The Innovation Agency has provided £856,000 funding

to a number of partners to support the development of

the following facilities:

• Health Innovation Campus, University of Lancaster,

first phase underway and due to open in 2018

• Liverpool Bio-Innovation Hub at University of

Liverpool, opened in February 2016

• Alder Hey Research and Education Centre opened

in October 2015

• Alder Hey Innovation Centre for digital and sensor

technologies opened in March 2016

• Centre for Integrated Health Science, Chester,

opened April 2015

• Accelerator Hub, Royal Liverpool & Broadgreen

University Hospital Trust (build underway)

• Chorley Digital Park, planning permission granted

The Innovation Agency’s commitment and support has

given confidence to others to invest.

Collectively these projects have secured over £55m

additional funding from sources including the NHS,

universities, industry, EU and UK Government.

We provide ongoing support to secure funding and

shape strategies, as well as to SMEs who locate within

the facilities to drive development and adoption of new

healthcare technologies.

These investments will establish a sustainable regional

infrastructure, creating jobs, developing skills and

attracting research funding and inward investment over

the long term.

The potential is there to drive significant economic

growth to the region in the coming years.

51

Case study – Alder Hey Children’s Hospital Alder Hey is one of ten innovation centres around

the North West Coast region being supported by

the Innovation Agency.

We provided two awards of infrastructure funding,

to the Institute in the Park research centre, helping

to leverage £12m European funding; and to create

a ‘living hospital lab’ where staff can try out new

technology in realistic clinical settings.

We organised events and brought in local

businesses who had products, services or advice

which were relevant to a set of needs identified by

the hospital. This match making led to several

strong relationships which have brought in

innovative devices and systems.

One ‘catalyst’ event at which a cardiologist presented a challenge to technology

developers, led to the creation of a joint venture to develop a small wireless sensor

to read defined signs of disease or abnormalities in the blood without breaking the

skin, avoiding the need for needles to take blood.

We also funded and supported a £50,000 telemedicine project implemented at three

sites to help families to access expert advice and support from consultants at Alder

Hey through remote video monitoring. Paediatric consultants use video technology

to monitor and assess children living with chronic neurological conditions at sites

including Southport and Ormskirk NHS Trust, Warrington and Halton Hospitals and

the Isle of Man.

52

Inward investment: Liverpool Bio-Innovation Hub

The Liverpool Bio-Innovation Hub

The Liverpool Bio-Innovation Hub (LBIH) offers a unique and beneficial

advantage to SMEs looking to grow their businesses in the biomedical sector.

The Innovation Agency invested £150,000 in this £20m project, and supported

the successful application to the European Regional Development Fund

(ERDF), to help realise the creation of a Hub for biomedical research and

personalised medicine through the construction of a high spec, state of the art

building to house a number of SMEs alongside valuable resources such as a

large, purpose-built biobank. LBIH is a state of the art incubator with 4,100sq m

available, for small and medium size enterprises co-located on University of

Liverpool campus, sited within the Knowledge Quarter and in next to the new

Royal Hospital currently under development.

The LBIH Biobank

The newly formed LBIH Biobank is a conglomeration of biobanks within the

University of Liverpool. The LBIH Biobank has been specifically created to

provide SMEs and academic researchers with high quality biosamples, data, and

analytical services. The LBIH Biobank houses a vast array of biosamples, both

cancerous and non-cancerous, and has the ability to collect bespoke samples

and data to suit the needs of researchers.

Currently, the LBIH Biobank has access to a wide variety of samples types

including but not limited to frozen tissue, fresh tissue, acetic fluid, blood products,

and FFPE blocks. The LBIH Biobank can further process these into a number of

products such as DNA, frozen sections, and cryo-aliquots. In order to offer a

‘one-stop shop’ for research, the LBIH Biobank offers additional services such as

IHC, next generation sequencing, and TMA creation and project management for

clinical trials, to include storage of trial samples.

53

Supporting staff and creating a culture for innovation to thrive

54

Supporting a staff culture of innovation

• We ran a project on behalf of NHS England for evidence

based commissioning

• Supported an NIHR funded work stream to produce easy

to understand research reports, ‘Signals’

• Supported an NIHR funded programme to analyse how

the 15 AHSNs are creating networks – reporting in June,

2016

• Established our online Innovation Exchange platform to

share proven innovations across the region and beyond

• Increased our Innovation Scout cohort to over 50 (see

next slide)

• Developed a checklist for NHS staff working with industry

• Ran a number of Hackathons for the region to produce

technology and service-based solutions for health and

social care systems

• Facilitated the adoption of approaches which support the

spread of innovation in NHS Trusts, eg Innovation

Breakfasts 55

Innovation Scouts – workplace champions

We increased our Innovation Scout cohort to over 50

and delivered a variety of development events

including:

• Master class from Professor Solomon Darwin of the

Berkeley Institute in California, leading to agreement

to pilot the Open Innovation approach, designed by

Professor Henry Chesbrough of Berkeley

• Master class from Dr Helen Bevan OBE

• Visits to innovative companies 3M and BAE.

Our Innovation Scout events have led to:

• Adoption of guidance: ‘Clearing the

confusing over medical app regulation'

• Production of guidance: 'How to work

effectively with industry'

• Industry offers to engage with the

Innovation Scouts from Lilly, BAE, 3M

• Developing capability through funding

Scouts on academic modules furthering

their knowledge

56

Supporting junior doctors

• Junior Doctors Dragons Den - an annual leadership and innovation event designed to inspire trainees to make change in their workplace and develop their skills and experience in leadership and management, run by Health Education England North West

• Supported North West Deanery/ Junior Doctor Advisory Team

• Four winning projects from a range of trusts

• Overall winner Our Healthy Future – gamified teaching sessions in healthy living, by Dr Jing Ouyang and Dr Muhammad Khan

• Two winners went on to gain places on the Clinical Entrepreneurs programme

57

Clinical Entrepreneur programme

We have partnered with NHS England and Health Education England and Lancaster University to design, recruit to and launch this programme, which is designed to keep the most forward-thinking, entrepreneurial clinicians within this country, bringing the benefit of cutting-edge new treatments and care pathways to the patients who need it – and keeping the money generated within the British economy.

One hundred of the brightest junior doctors who have a clinical innovation or enterprise currently under development have been selected for the Clinical Entrepreneur Fellowship under the brand-new training scheme, receiving mentorship from international entrepreneurs and health innovators.

A core training scheme, will offer crash-courses and bite-sized study in starting and running a business, regulation and governance, and building investment.

The programme is being piloted at Lancaster University from 2016. Over the coming years, both the fellowship and the core training scheme will be rolled out to nurses, midwives and allied health professionals, to harness the knowledge, skills and experience of all England’s clinicians. This scheme is easily replicable and could be rolled out across geographical boundaries.

58

Supporting our own staff

We are delivering a comprehensive innovation

training package to our staff and providing

resources they can use to demonstrate how

innovation can be deployed.

We were successful in achieving the Investors

in People Silver Award and are being

assessed for the Gold Award in Summer 2016.

59

North West Procurement Development supports procurement and finance staff to be competent in

• - procuring for innovation

• - procuring for value/ outcomes not just cost

We support them by:

• - chairing the advisory board – our CEO Dr Liz Mear

• - individual commissions of work

• - supporting the Excellence in Supply Awards

• - supporting an annual procurement good practice showcase

Supporting procurement, finance

60

Presentation 1

Supporting frontline staff in the community

Assistive Living Technology and Skills – ALTAS

We are a partner in this EU project to develop online

learning for health and social care staff, that will

ultimately enable their clients to benefit from smart

solutions to live independently, self-care and improve

their health and well-being.

Once completed this package of e-learning will be

rolled out across Europe.

61

North West Learning and Development Collaborative

The North West Learning and Development

Collaborative includes the Innovation Agency, Greater

Manchester Academic Health Science Network, AQuA,

the North West Leadership Academy and Health

Education England.

Our collaboration has created a connected set of

partners who have well established, formal and

informal relationships. The depth and breadth of these

relationships enables alignment of combined skills and

resources to tackle the challenges facing the North

West health and social care economy

All the development work undertaken by

these bodies in the North West is

designed to transform the way we meet

the needs of the population and improve

outcomes, creating the cultures

necessary to deliver the vision outlined

within the 5 Year Forward View.

The Collaborative harnesses the region’s

improvement and leadership development

communities to enable innovation to

thrive. The Collaborative provides

development for boards, leaders,

managers; it supports coaching skills,

mentoring skills, Lean methodology and

improvement methodology for front line

staff.

Creating this climate supports a culture of

innovation across the North West Coast.

62

AQuA – Advancing Quality Alliance

Since our inception we have commissioned

AQuA to support North West Coast AHSN

NHS members to deliver service improvement,

including the building of capability in

improvement science at all levels, and

collaborative programmes of action to deliver

demonstrable improvement in safety,

effectiveness and patient experience.

This includes Board development, Shared

Decision Making skills development and

leadership for safety programmes and

reducing mortality work. A shared fee between

the two organisations, funds this work.

63

In addition to this shared fee arrangement, over

the last two years we have separately

commissioned the:

•

Patient Safety Collaborative Network

Sustainability and Spread Programme;

Leadership Programme (Focus on safety

within the Care Home setting).

Some of the work from these two programmes

will be rolled out in 2016/17.

Digital health

64

Presentation 1

Digital health

Working with the European Connected Healthcare

Alliance (ECHA), the Innovation Agency has

developed a region-wide ecosystem to enable better

connected health and economy growth through digital

innovations.

This work is linked to a further 24 ecosystems across

Europe, offering the opportunity to develop at pace

through sharing and learning of best practice.

As part of the ecosystem work, the Innovation Agency

has developed a connected health working group

which consists of key regional leaders who meet every

six weeks to drive the work forward.

The Innovation Agency is a key participant a the

Lancashire Digital Health Board and has co-funded

projects that report to this Board re the digital literacy

programme and the rollout of the Strata IT handover

tool.

Our digital health programme became an underpinning

goal in 2016/17 as we incorporate digital methods of

delivering healthcare into all pathways.

65

Presentation 1

Interoperability

The Innovation Agency has supported programmes to improve interoperability and the flow of electronic information across care pathways to front line staff, patients and carers.

LPRES

We have supported LPRES (Lancashire Person Record Exchange Service), an innovative solution breaking new ground in the NHS with the introduction of an ‘on demand’ model for sharing information. The scalability of this approach means information can be exchanged both within and across a region.

iLINKS

Support has been given to the North Mersey iLINKS Programme, hosted by Liverpool CCG. This is an enabler for commissioner and provider transformation strategies, supporting the move to a culture in which clinical information is shared by default.

A key priority for the programme is the development of a scaled sharing and information governance model for the whole economy which will be enabled by a digital interoperability roadmap.

66

We have played and continue to play a key role in the Connected

Health Cities (CHC) programme, which demonstrates the

Government’s commitment to the Northern Powerhouse.

There are four CHC pilots in the North of England - North West

Coast; Greater Manchester; North East and North Cumbria; and

Yorkshire and Humber. The aim is to use data to deliver a more

connected health system for staff and citizens.

We have been awarded £4 million to deliver the CHC in the North

West Coast and have four key work-streams:

• Clinical pathways – the University of Liverpool is

developing two pathways, for COPD and alcohol,

alongside all relevant service providers. These

workstreams build on existing infrastructure in the region

• The Ark – led by Lancaster University, which will develop

our region’s frontline staff in digital skills and analysis

• Infrastructure – led by AIMES Grid Services who will

provide the systems for housing and organising the data

and support the liaison with industry and linking of data-

sets

• The Innovation Agency will provide oversight and support

for citizen involvement, interdependencies and spread at

pace and scale of the programme outputs

Connected Health Cities

67

Presentation 1

Using technology to improve efficiency –

E-Referral in Cumbria and Lancashire In Cumbria, health and care organisations, led by Cumbria CCG and Strata Health, have been involved in using innovative e-referrals software system as well as resource matching software to minimise waiting for places in intermediate care and rehabilitation beds.

In Cumbria alone there has been more than 15,000 e-referrals in the last year, leading to:

• a reduction in unproductive nursing / social care time resource worth over £300,000

• a reduction in reliance on paper, fax, filing and copying of patient files, by both senders and receivers valued at around £20,000

• improved communications between multi agency health and care staff, speeding up the patient transition

This programme is also rolling out across Lancashire CCG and health and social care partners.

68

Presentation 1

European programmes - StopandGo STOPandGO is a Public Procurement of Innovation pilot project co-funded

by the ICT Policy Support Programme of the European Union. The goal of

STOPandGO is to produce and validate reference material that will support

the development of coherent procurements across Europe regarding the

provision of innovative healthcare and social services enhanced by

technology, for elderly people.

The STOPandGO procurement process focuses on the integration and the

simultaneous improvement of models of care and cure, to provide services

augmented by a coherent set of interoperable technologies. It is hoped that

the project will benefit more than 5000 citizens and service areas will

include diabetes, integrated care, domiciliary care and dementia.

There are multiple partners across four countries - UK, Netherlands, Italy

and Spain. The Innovation Agency is one of the knowledge partners in the

UK together with procurement groups from Eastern Cheshire CCG and

Liverpool City Council.

The Diabetes Care and Domiciliary Care Services proposed in the UK will

benefit a significant number of citizens in our region. The €4m

procurements from the project receive a generous contribution from the

EU, further supporting the providing partners in the region.

Ann Williams of Liverpool City Council said: “This is an exciting

opportunity which brings both domiciliary care providers and technology

companies to work together to deliver a better quality service while

providing value for money. By being part of the StopandGO programme

we will receive €400,000 to procure innovative solutions and are learning

with colleagues across Europe about the best way to procure technology

into services for older people.”

Speed dating at a STOPandGO

event for care providers and tech

businesses

69

European Institute of Innovation & Technology Health Knowledge and Innovation Community - EIT Health KIC The Innovation Agency is an Associate Partner of EIT Health KIC. EIT Health promotes entrepreneurship and innovates in healthy living and active ageing, providing Europe with new opportunities and resources. It enables citizens to lead healthier and more productive lives by delivering products, services and concepts that improve quality of life and contribute to the sustainability of healthcare across Europe.

EIT Health is one of the largest healthcare initiatives worldwide, headquartered in Munich. Its goal is to sustainably advance the foundations of healthcare and thus promote the future conditions for healthier living and wellbeing of people across Europe. EIT Health is leveraging the expertise of more than 130 leading organisations spanning key areas of healthcare such as Pharma, MedTech, Payers, Research Institutions and Universities. Chosen by the European Institute of Innovation and Technology (EIT) to form EIT Health, the consortium offers best-in-class research capabilities, higher education and business expertise. With a budget of 2 billion EUR over the next decade, it will purposefully invest in Europe’s best entrepreneurial talents and creative minds to foster the development and commercialisation of smart product and service solutions in the health sector, addressing the challenges imposed by demographic change and ageing societies.

EIT Health will focus investments on innovative products and services which support people in their desire for self-management of their health (“Promote Healthy Living”), and to ensure they stay professionally and socially connected and active throughout life (“Support Active Ageing”), whilst EIT Health also seeks to ensure better integration of healthcare services and provisions (“Improve Healthcare”).

70

Sharing and learning with partners

71

Presentation 1

Building our networks We have engaged with our partners and

stakeholders through a wide range of methods,

including:

• Bimonthly e-newsletter

• Events in 2015/16 included workshops,

hackathons, summits, working lunches, focus

groups and award presentations

• Digital connected health ecosystem quarterly

events

• Establishing a platform for matching health and

care partners with innovation solutions – the

Innovation Exchange, to be launched summer

2016

• Press releases, blogs, website content and

social media

• Innovation Scouts

• Bespoke pieces of work for partners

72

Presentation 1

Hackathons – the impacts

We have supported two hackathons in the region:

Alder Hey Children’s Hospital – ‘Hacking Children’s

Health’

Winning pitch: Producing sensor technology to avoid

tissue damage from intravenous lines

Also, Alder Hey Chairman Sir David Henshaw was so

impressed by the Hackathon ideas that he launched an

Innovation Fund to support staff innovation.

Central Cheshire System Resilience Group – HACK

2016

Winning pitch: Creating a single point of access for GPs

and health professionals

Innovation Agency Hack team: A workshop was held by

the Massachusetts Institute of Technology (MIT) Hacking

Medicine Team following the Alder Hey event, for our staff

and Innovation Scouts. This led to the Innovation Agency

establishing our own hack team to work with partners

across the region to develop hackathon facilitator skills and

co-deliver health and care hackathons.

Our hack team: Lisa Butland, Juliet te Kumar,

Jen Gilroy-Cheetham, Catherine Gresty

73

In November 2015, the Innovation Agency alongside the

CRN and the CLAHRC NWC ran a celebration event to

showcase the leading innovation and research that is being

rolled out across the region. The NIHR Clinical Research

Network is the clinical research delivery arm of the NHS.

They operate across England through a national

coordinating centre and 15 local branches delivering

research in the NHS across all disease areas.

NHS England

NHS England is the main funder of all AHSNs and assure

themselves on a quarterly basis that the Innovation Agency

is meeting its duties in accordance with the Innovation,

Health and Wealth principles, and in line with the objectives

of the Five Year Forward View.

The Innovation Agency has a close working relationship with

NHS England North and the sub-regional teams as well as a

strong relationship with colleagues on a national level. Our

vision of reducing health inequalities and contributing to a

vibrant local and national economy are consistent with the

principles of NHS England.

Partnerships with other organisations

Clinical Networks

The AHSN’s health innovation priority areas have been

closely aligned with the two North West Strategic Clinical

Networks (SCNs). The SCN works to agree clinical

pathways with commissioners and AHSNs put these tested

pathways into practice. The AHSN has worked with the

SCNs in the areas of stroke/AF, neurological health, cancer

and mental health. Moving into 2016/17 there is one

Clinical Network for the North West Coast.

NIHR CLAHRC NWC

Research collaborations across industry, academia and the

NHS have been further stimulated as a result of the

partnership with the NIHR North West Coast Collaboration

for Leadership in Applied Health Research and Care (NIHR

CLAHRC NWC). The CLAHRC NWC is an important

partner for the Innovation Agency as our objectives and

outcomes are closely aligned, The two organisations have

worked together on programmes for neurological health,

mental health, genotyping for warfarin use and evaluation

of stroke treatments and have run joint events.

NIHR CRN NWC

The Innovation Agency has supported the NIHR Clinical

Research Network (CRN) in working closely with

colleagues to develop research, innovation and

improvement capacity.

74

Well North The Innovation Agency is a supporter and contributor to the Well North Project, which is funded by Public Health England and local regions. This project seeks to promote a move from a high cost medical model to a high value healthcare system, by harnessing the strengths of local citizens. The aims of the programme are to :

Address inequality by improving the health of the poorest, fastest

Reduce levels of worklessness, a cause and effect of poor health

Reduce premature mortality

• There are three Well North sites in the NWC area - in Sefton, Halton and West Lancashire.

Partnerships (contd)

Liverpool Health Partners (LHP) brings together

clinical and scientific expertise to develop and

promote world-leading research, education,

healthcare and innovation.

They are made up of a core group of founding

partners and a network of members.

They are one of three research hubs in the

footprint of the Innovation Agency and are

supported by us. LHP provides the bio-medical

research pipeline into the region and contributes

to and benefits from the success of the Innovation

Agency's work to enhance the North West Coast's

reputation and profile for health research

In 2015 LHP and the Innovation Agency ran the

Health is Wealth conference. The Innovation

Agency is part-funding this conference again in

2016/17.

Liverpool Health and Wellbeing Board: Our

Chair Gideon Ben-Tovim OBE is a Board

member.

75

The Health Hub facilitates cross-sectoral working and

brings together local organisations around specific aims

and themes, both to deliver large projects and

programmes, and to advance local infrastructure for

research and healthcare. For example, the Health Hub

recently led a successful application for an NHS England

Test Bed, demonstrating its value in leveraging funding

for major initiatives through its in-depth knowledge of,

and relationships with, individual organisations.

The Health Hub both contributes to and benefits from

the success of the Innovation Agency's work to enhance

the North West Coast's reputation and profile for health

research and innovation. Examples of the Health Hub's

current collaborations with the Innovation Agency

include joint bidding for EU funding, joint working to

deliver the Test Bed, and joint working to develop the

Lancaster Health Innovation Campus.

Partnerships (contd)

Lancaster Health Hub

Lancaster Health Hub is a strategic partnership

involving 10 health organisations across Lancashire

and Cumbria. It enables the partner organisations to

work together to drive locally-led research and

innovation, to enhance evidence-based, high quality

healthcare, and to support local economic growth and

job creation.

The partnership draws upon skills and expertise in all

academic departments at Lancaster University, which

is rated within the top 10 UK universities. The

partnership comprises: Lancaster University, University

of Cumbria, Blackpool Teaching Hospitals NHS

Foundation Trust, Calderstones Partnership NHS

Foundation Trust, Lancashire Care NHS Foundation

Trust, Lancashire Teaching Hospitals NHS Foundation

Trust, University Hospitals of Morecambe Bay NHS

Foundation Trust, Lancashire North CCG, NHS Fylde

and Wyre CCG and Healthwatch Lancashire.

76

Partnerships with other organisations The Northern Health Science Alliance Ltd

The Northern Health Science Alliance Ltd

(NHSA) is a partnership established by the

leading universities and NHS hospital trusts in

the North of England to improve the health and

wealth of the region by creating an

internationally recognised life science and

healthcare system.

Our CEO Dr Liz Mear sits on the NHSA Board

and Council.

The NHSA links eight universities and eight

NHS teaching trusts with the AHSNs. Together

the Alliance and the four Northern AHSNs

cover a patient population of over 15 million

people. The NHSA acts as a single portal

bringing together research, health science

innovation and industry to provide benefits for

researchers, universities, hospitals, patients as

well as commercial partners.

77

Partnership with NWC universities – a strategic approach

The Innovation Agency has established a strategic approach for

engagement with all nine NWC universities, in consultation with

each Vice Chancellor.

Twice-yearly Academic Summits are held, involving external

speakers, to bring together all NWC universities.

Discussions at Summits have enabled a focus for future joint

working to be identified around Horizon 2020:

• Identifying core themes for collaborative bidding

• Preparing and submitting joint proposals

• Enabling wider participation in EU networks, events and

workshops

Senior academic leads have been identified in each university to

provide a formal point of liaison with the Innovation Agency.

We have established directories of NWC universities’ skills and

facilities for health innovation; and professional programmes for

health innovation and leadership.

We support university-based posts and initiatives to develop

innovation centres and to build capability in innovation and

knowledge mobilisation across the NWC.

78

Northern AHSN Forum

This forum, which meets bi-monthly includes all four

Northern AHSNs. The forum is used for planning joint

work, updating on progress of national and regional

initiatives and sharing lessons that can accelerate the

progress of work streams that benefit residents, industry

and staff.

Evidence based approaches for managing Alcohol

Issues

We have worked with Oxford AHSN/ the NICE

Improvement Collaborative (NIC) to develop and deliver

a report about using evidence-based technologies in

managing alcohol issues.

Genomic Ambassador

Over the last year we have provided much support for

this programme. In 2016/17 our support is to fund a

specific post for adoption and spread of the programme

across the region. This Genomic Ambassador post

based on a model developed by West Midlands AHSN.

Collaborations with other AHSNs AHSN Network

During 2015 our CEO Dr Liz Mear became Vice Chair of

the AHSN Network and in April 2016 became Chair of the

Network.

During 2015/16 the AHSN Network developed an adoption

and spread process across the 15 AHSNs. Two topics

have been chosen – Stroke/AF innovations and Flo (a

digital messaging platform).

The Innovation Agency takes part in a number of AHSN

Network wide meetings including one for chief executives/

managing directors, commercial directors, directors of

improvement and communications leads. These frequent

meetings allow the AHSNs to accelerate adoption of

innovation, share learning and collaborate on wealth

creation initiatives. These groups also spread learning

across the country and work on joint projects for the benefit

of residents and industry. NWC, along with West of

England and West Midlands AHSNs, designed a format for

national learning events. The first event on mental

health/dementia generated 30 collaborations for the

adoption of innovations across all 15 AHSNs.

79

Looking forward

80

Presentation 1

Looking Forward

81

Financial performance

82

Presentation 1

Finance report

All programme budgets are shown minus staff costs , for example when staff

costs are included the cost of running the Patient Safety Collaborative was

£760k.

83

If you would like to work with us and make a difference to the lives of millions of local people, please contact:

Dr Liz Mear Chief Executive E: Liz.Mear@innovationagencynwc.nhs.uk T: 01772 520260 M: 07891 698692

Lisa Butland

Director of Innovation and Research E: Lisa.Butland@innovationagencynwc.nhs.uk T: 01772 520263 M: 07900 715261

Prof John Goodacre

Medical Director E: John.Goodacre@innovationagencynwc.nhs.uk T: 01772 520258 M: 07538 902165

Lorna Green

Commercial Director E: Lorna.Green@innovationagencynwc.nhs.uk T: 01772 520259 M: 07507 845982

Email: info@innovationagencynwc.nhs.uk Twitter: @innovationnwc

www.innovationagencynwc.nhs.uk

Caroline Kenyon

Director of Communications and Engagement

E: caroline.kenyon@innovationagencynwc.nhs.uk

T: 01772 520256

M: 07950 866394

84

Presentation 1

The Innovation Agency team

85

We are the Innovation Agency – committed to improving lives

in the North West Coast. Thank you for reading our annual

report 2015-16.